Pascal’s responsibilities include managing relationship with internal and external stakeholders related to serialization and track and trace. He represents Pfizer externally on various industry groups related to the implementation of the European Falsified Medicines Directive at European and country level and liaises internally with the Pfizer Global Serialization Program and market colleagues to implement the requirements.
Pascal is co-leading the Pfizer FMD implementation project for Europe and is involved also in the other projects or initiatives for the EMEA region where published or drafted legislation for serialization exist. He is the EFPIA representative in the European Medicines Verification Organization Technical Advisory Group and member of the French trade association steering committee for the FDM implementation where he works in different workstreams with the other stakeholders. Since 2017, he represents Pfizer in the GS1 Healthcare Leadership Team. Pascal has 19 years of experience in the industry.